Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Cash from Investing Activities came in at -$4.1 million in Q1 2026, up 6.74% year-on-year from -$3.8 million in Q1 2025, and down 32.9% on a QoQ basis from -$3.1 million in Q4 2025.

Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Cash from Investing Activities data on file, last reported at -$4.1 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 6.74% year-over-year to -$4.1 million in Q1 2026; TTM through Mar 2026 was -$12.9 million, a 20.82% decrease from a year earlier, with the FY2025 full-year figure at -$13.2 million, down 87.09% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$4.1 million, down from -$3.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for JUSHF reached as high as $1.7 million in Q2 2024 and fell as low as -$38.1 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$4.1 million in 2026.
  • On a YoY basis, Cash from Investing Activities climbed as much as 348.1% in 2024 and fell as far as 2112.2% in 2024.
  • Year by year, Cash from Investing Activities stood at -$7.7 million in 2022, then jumped by 95.76% to -$328000.0 in 2023, then plunged by 2112.2% to -$7.3 million in 2024, then surged by 57.69% to -$3.1 million in 2025, then tumbled by 32.9% to -$4.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$4.1 million in Q1 2026, -$3.1 million in Q4 2025, and -$5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.49 Bn 30.55 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.13 Bn 20.97 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn -4.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.08 Mn
Mar 31, 2026 -4.08 Mn
Dec 31, 2025 -3.07 Mn
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 -5.32 Mn
Sep 30, 2025 -5.32 Mn
Jun 30, 2025 -459,000.00
Jun 30, 2025 -459,000.00
Mar 31, 2025 -4.38 Mn
Mar 31, 2025 -4.38 Mn
Dec 31, 2024 -7.26 Mn
Dec 31, 2024 -7.26 Mn
Sep 30, 2024 -770,000.00
Sep 30, 2024 -770,000.00
Jun 30, 2024 1.70 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 -743,000.00
Mar 31, 2024 -743,000.00
Dec 31, 2023 -328,000.00
Dec 31, 2023 -328,000.00